Study at a glance
Can vitamin D3 or omega-3 supplements change telomere length?
Researchers asked whether vitamin D3 or omega-3 supplements changed telomere length in older adults over four years. Telomeres are sections at the ends of chromosomes, the structures that carry genetic material. They help protect that material when cells divide and shorten as cells divide. The study measured telomeres in immune cells in the blood.
How were the vitamin D3 and omega-3 supplements tested?
People were placed into supplement or placebo groups by chance. A placebo contains no active treatment. Researchers compared vitamin D3, omega-3, both supplements and placebo. The analysis used 2,571 measurements from 1,031 people, taken at the start and after two and four years.
Did vitamin D3 or omega-3 change telomere shortening?
The vitamin D3 group had slightly less telomere shortening than the placebo group over four years. The difference met the study’s statistical test. Omega-3 showed no clear effect on telomere length at either follow-up. Taking both supplements did not show an additional effect beyond vitamin D3 alone.
Does less telomere shortening prove slower ageing?
No. The analysis did not measure lifespan, disease prevention or people’s ability to carry out daily activities. The test combines results from different immune cells, and changes in that mixture can affect the measurement. These findings describe differences between groups. They do not show how fast one person is ageing, prove a health benefit or explain why the difference occurred.
Read the full article below ↓Evidence from a prespecified ancillary analysis of leukocyte telomere length within a large randomized controlled trial.
Study classification and identity
Study type
Randomized controlled trial, prespecified ancillary analysis
Parent study
VITamin D and OmegA-3 TriaL (VITAL)
Ancillary study focus
Longitudinal leukocyte telomere length dynamics
Exposure type
Randomized exposure to vitamin D₃ and/or marine omega-3 fatty acids
Intervention arms
Vitamin D₃ (2,000 IU/day)
Marine omega-3 fatty acids (1 g/day)
Combined vitamin D₃ and omega-3 fatty acids
Placebo
Primary endpoint category
Biological marker (leukocyte telomere length)
Clinical endpoints assessed
Not applicable in this study
Study purpose and framing
This prespecified ancillary study examined whether randomized exposure to vitamin D₃ and/or marine omega-3 fatty acids altered the longitudinal trajectory of leukocyte telomere length over four years within a large, double-blind, placebo-controlled randomized controlled trial.
Leukocyte telomere length was evaluated as a population-level biological marker reflecting cumulative cellular maintenance processes over time rather than as a clinical outcome or a direct measure of ageing phenotype.
Why leukocyte telomere length is used as a biological marker
Telomeres are repetitive nucleotide sequences located at the ends of chromosomes that preserve genomic stability during cell division. With successive replication cycles, telomeres progressively shorten, reflecting cumulative cellular replication history, oxidative stress exposure, and efficiency of telomere maintenance systems.
Because telomere shortening unfolds gradually, leukocyte telomere length is widely used in population research as a marker associated with long-term cellular ageing processes rather than acute physiological change. Baseline telomere length varies substantially across individuals, and longitudinal changes are interpreted at the group level.
Leukocyte telomere measurements represent an aggregate signal across circulating immune cell populations. Shifts in immune cell subtype composition over time can influence measured telomere length independently of telomere dynamics within specific cell types.
Study overview
The VITAL trial was a large, randomized, double-blind, placebo-controlled clinical trial conducted in the United States using a 2 × 2 factorial design. The parent trial enrolled 25,871 participants, including women aged 55 years and older and men aged 50 years and older, with follow-up of up to five years.
Participants were randomly assigned to receive vitamin D₃, marine omega-3 fatty acids, both interventions, or placebo. The telomere analysis was conducted as a prespecified ancillary study embedded within this trial framework.
Study design and measurement approach
The telomere ancillary study included 1,054 participants who attended in-person study visits at the Harvard Clinical and Translational Science Center. Leukocyte telomere length was measured at baseline, year 2, and year 4.
Telomere length was assessed using a quantitative polymerase chain reaction: based assay described as Absolute Human Telomere Length Quantification. This approach is suitable for longitudinal population studies but is subject to technical and biological variability and does not yield precise individual-level telomere measurements.
Outcome hierarchy
Directly measured
Change in leukocyte telomere length over time
Not measured
Clinical outcomes
Disease incidence
Functional ageing metrics
Lifespan or mortality
Not inferable from this study
Individual ageing rate
Disease risk modification
Causal biological mechanisms linking vitamin D₃ exposure to telomere maintenance
Statistical analysis
The prespecified primary outcome was change in leukocyte telomere length between baseline, year 2, and year 4. Intervention effects were analysed using mixed-effects linear regression models to account for repeated measurements within individuals over time.
A total of 2,571 telomere measurements were obtained from 1,031 participants across the three time points. Analyses compared telomere attrition trajectories among participants assigned to vitamin D₃ supplementation, omega-3 fatty acid supplementation, combined supplementation, or placebo.
Results
Over the four-year follow-up period, participants randomized to vitamin D₃ supplementation exhibited a statistically significant attenuation of leukocyte telomere length attrition compared with those assigned to placebo.
Vitamin D₃ supplementation was associated with a reduction in telomere attrition of approximately 0.14 kilobase pairs (140 base pairs) over four years relative to placebo (95% confidence interval: 0.007 to 0.27 kilobase pairs; p = 0.039). Trend analyses indicated that telomere length was approximately 0.035 kilobase pairs higher per year among participants receiving vitamin D₃ compared with placebo (95% confidence interval: 0.002 to 0.07 kilobase pairs; p = 0.037).
Marine omega-3 fatty acid supplementation did not demonstrate a statistically significant effect on leukocyte telomere length at either year 2 or year 4. Combined supplementation did not produce effects beyond those observed for vitamin D₃ alone within the study timeframe.
Measurement considerations and limitations
Leukocyte telomere length measured by qPCR reflects an aggregate signal influenced by both telomere dynamics and circulating immune cell composition. Changes in leukocyte subtypes may contribute to observed differences independently of telomere maintenance within specific cell populations.
While qPCR-based methods enable efficient longitudinal assessment in large cohorts, they are less precise than alternative techniques such as Southern blot terminal restriction fragment analysis or flow cytometry: based approaches. Findings are therefore interpreted at the group level rather than as exact telomere measurements in individuals.
As an ancillary study, the telomere cohort represents a subset of the parent VITAL population. Selection factors and representativeness should be considered when generalising results beyond the studied group.
Generalisability and population context
The study population consisted of older adults, with enrolment beginning at ages 50 to 55 years depending on sex. Telomere dynamics observed in this context reflect ageing-related biological processes within later adulthood.
Findings may not generalise to younger populations, to individuals with substantially different baseline vitamin D status, or to populations with different genetic, environmental, or lifestyle backgrounds.
Mechanistic inference boundary
This study did not test biological mechanisms linking vitamin D₃ exposure to telomere biology. The observed association describes differences in telomere attrition trajectories under randomized exposure conditions and remains consistent with, but does not confirm, hypotheses relating vitamin D signalling to cellular maintenance environments.
No mechanistic pathway can be inferred from these data.
Interpretation within vitamin D physiology
Vitamin D biology interacts with multiple regulatory systems that evolve with age, including immune cell function, inflammatory signalling, and endocrine feedback mechanisms. The observed association between vitamin D₃ exposure and telomere attrition patterns should be interpreted within the broader context of age-related changes in vitamin D handling and responsiveness.
For a physiological overview of how age modifies vitamin D biology, see Vitamin D and age.
Interpretation
Within the context of a large randomized controlled trial, vitamin D₃ exposure was associated with a modest attenuation of leukocyte telomere attrition over four years. These findings describe population-level biomarker dynamics under controlled exposure conditions and do not establish clinical benefit, ageing modification, or individual health effects.
The results should be interpreted strictly within the boundaries of biomarker research, study duration, population characteristics, and measurement methodology.
Primary source and publication details
Zhu H, Manson JE, Cook NR, et al.
Vitamin D₃ and marine ω-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from the VITamin D and OmegA-3 TriaL (VITAL) randomized controlled trial.
American Journal of Clinical Nutrition. 2025.
DOI: 10.1016/j.ajcnut.2025.05.003
https://pubmed.ncbi.nlm.nih.gov/40409468/
Related reading
25-Hydroxyvitamin D Concentration and Leukocyte Telomere Length in Young Adults: Findings From the Northern Finland Birth Cohort 1966
Higher vitamin D status, lower adiposity, and longer telomere length are each reportedly associated with lower risk of several chronic diseases and all-cause mortality.
Original paper ↗Read more →A role for vitamin D and omega-3 fatty acids in major depression? An exploration using genomics
Trials testing the effect of vitamin D or omega-3 polyunsaturated fatty acid (n3-PUFA) supplementation on major depressive disorder (MDD) reported conflicting findings.
Original paper ↗Read more →Aging and the impact of global DNA methylation, telomere shortening, and total oxidative status on sarcopenia and frailty syndrome
The study aimed to determine the associations between these processes, frailty and sarcopenia syndrome.
Original paper ↗Read more →An Update on Protein, Leucine, Omega-3 Fatty Acids, and Vitamin D in the Prevention and Treatment of Sarcopenia and Functional Decline
Aging is associated with sarcopenia and functional decline, leading to frailty and disability.
Original paper ↗Read more →Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer’s disease
This review aims to summarise evidence reported by observational studies and clinical trials that investigated the role of LC ω3 PUFAs against cognition impairment and future risk of Alzheimer’s disease.
Original paper ↗Read more →Dietary Inflammatory Index and cardiometabolic and inflammatory profiles in children and adolescents with type 1 diabetes: a cross-sectional study
This study evaluated whether higher DII scores are associated with poorer glycemic control and adverse inflammatory profiles in children and adolescents with T1DM.
Original paper ↗Read more →Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population
Our aim was to evaluate the association between the intake of different fish species, PUFA and vitamin D and the prevalence of psychotic-like symptoms in a population-based study among Swedish women.
Original paper ↗Read more →Effects of krill oil and lean and fatty fish on cardiovascular risk markers: a randomised controlled trial
Krill oil is an alternative source of marine n-3 fatty acids and few studies have investigated its health effects.
Original paper ↗Read more →Effects of Vitamin D, Melatonin, and Omega-3 Fatty Acids on Periodontal Health: A Narrative Review
Periodontitis is a chronic inflammatory disease characterized by the destruction of tooth-supporting structures, influenced by immune system dysregulation, oxidative stress, and imbalances in bone metabolism.
Original paper ↗Read more →Identification of Neuroprotective Factors Associated with Successful Ageing and Risk of Cognitive Impairment among Malaysia Older Adults
Therefore, this study aimed to identify neuroprotective factors for cognitive decline in different ageing groups.
Original paper ↗Read more →Interaction of Vitamin D Supplements and Marine n-3 Fatty Acids on Digestive Tract Cancer Prognosis
This study aimed to investigate the potential interaction between vitamin D supplementation and serum EPA and DHA levels.
Original paper ↗Read more →Leukocyte Telomere Length as a Marker of Chronic Complications in Type 2 Diabetes Patients: A Risk Assessment Study
T2D patients with the shortest LTL had higher TC and non-HDL levels, compared to subjects with the longest LTL (p = 0.013).
Original paper ↗Read more →Nutritional Knowledge, Dietary Behaviours and Supplementation Practices Among Pregnant Women in Poland: A Repeated Cross-Sectional Study Across a Decade
Compared with 2008 to 2010, women surveyed in 2017 to 2019 more often had higher education and more frequently reported income above the predefined questionnaire threshold.
Original paper ↗Read more →Omega-6/omega-3 fatty acid intake of children and older adults in the U.S.: dietary intake in comparison to current dietary recommendations and the Healthy Eating Index
With these analyses, we aimed to describe omega-6 and omega-3 FA intake among children and older adults in light of FA intake recommendations and with consideration of overall diet.
Original paper ↗Read more →One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)
We examined these VITAL200, a nested substudy of 200 subjects balanced on demographics and treatment and randomly selected from the Vitamin D and Omega-3 Trial (VITAL).
Original paper ↗Read more →Serum levels of vitamin E, vitamin D, and omega-3 fatty acids in patients with generalized chronic periodontitis: A cross-sectional study
The present study aimed to investigate the serum levels of vitamin D, vitamin E, and omega-3 in patients with chronic periodontitis.
Original paper ↗Read more →The association of serum levels of vitamin D with leucocyte telomere length, as a marker of biological aging: A meta-analysis
A total of 21 studies comprising 185,191 participants were analyzed.
Original paper ↗Read more →The effect of omega-3 and vitamin D co-supplementation on glycemic control and lipid profiles in reproductive-aged women with pre-diabetes and hypovitaminosis D: a randomized controlled trial
A significant reduction was observed in fasting glucose, insulin, homeostasis model assessment-beta cell function, weight and waist circumference in the co-supplementation group compared to the other three groups (P.
Original paper ↗Read more →The effects of fatty fish intake on adolescents’ nutritional status and associations with attention performance: results from the FINS-TEENS randomized controlled trial
Participants were individually randomized to receive either fish meals, meat meals or n-3 LCPUFA supplements, three times a week for a total of 12 weeks.
Original paper ↗Read more →Very Low and High Levels of Vitamin D Are Associated with Shorter Leukocyte Telomere Length in 148,321 UK Biobank Participants
In this study, we examined the relationship between vitamin D levels and LTL in older participants of the UK Biobank.
Original paper ↗Read more →Vitamin D and omega-3 fatty acids attenuate MSG-induced neurodegeneration by modulating tau pathology, neuroinflammation, and VDR expression in rats
Fifty male Sprague Dawley rats were randomly allocated to a control, an MSG, and three treatment groups that received MSG and either Vit D or N-3 PUFA supplements in combinations or alone for 4 weeks.
Original paper ↗Read more →Original sources
https://pubmed.ncbi.nlm.nih.gov/40409468/
https://pubmed.ncbi.nlm.nih.gov/40409468/.
Publication details
https://pubmed.ncbi.nlm.nih.gov/40409468/